OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program (Q33661856)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program |
scientific article |
Statements
1 reference
OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program (English)
1 reference
R B Lipton
1 reference
S K Aurora
1 reference
D W Dodick
1 reference
H-C Diener
1 reference
R E DeGryse
1 reference
C C Turkel
1 reference
S D Silberstein
1 reference
20 September 2013
1 reference
1 reference
129
1 reference
61-70
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference